Onsite Buprenorphine Treatment at Syringe Exchange Programs

Completed · Phase 2

Conditions studied: Opiate Addiction

In brief

This trial will recruit syringe exchange participants with opioid use disorder in New York City and test whether starting buprenorphine treatment at the syringe exchange program is more effective than referral to a community health center for buprenorphine treatment.

Key facts

Study ID

NCT03150173

Run by

Montefiore Medical Center

People needed

97

Starts

2019-01-02

Expected to finish

2024-03-31

Last updated by the study team

2025-12-11

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• age ≥ 18 years
• opioid use disorder
• interest in buprenorphine treatment
• motivation for opioid use disorder treatment
• willingness to accept community health center referral
• syringe exchange participant

You may not qualify if…

• receiving opioid agonist treatment in the past 30 days (confirmed by New York Prescription Drug Monitoring Program);
• inability to provide informed consent
• unstable mental illness (e.g., suicidality, psychosis, etc.)
• severe alcohol use disorder or benzodiazepine use disorder by the Diagnostic and Statistical Manual of Mental disorders, Fifth Edition (DSM-5) criteria
• hypersensitivity to buprenorphine or naloxone.
• pregnancy (confirmed via urine testing)

Where it is running

• Washington Heights CORNER Project — New York, New York, United States
• New York Harm Reduction Educators — New York, New York, United States
• BOOM!Health Harm Reduction Center — The Bronx, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.